PDS BIOTECHNOLOGY CORP : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On February 8, 2023, PDS Biotechnology Corporation issued a press release
announcing preclinical studies involving Infectimune™, PDS Biotech’s novel
investigational immune activating platform, were published in the peer-reviewed
journal, Viruses, demonstrating the technology’s ability to generate a broad
immune response against viruses, including SARS-CoV-2 and multiple strains of
influenza.

A copy of the press release is filed herewith as Exhibit 99.1 and incorporated
by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit
 Number                                    Description

  99.1     Press Release Dated February 8, 2023.
  104      Cover Page Interactive Data File (embedded within the Inline XBRL Document)

——————————————————————————–

© Edgar Online, source Glimpses